News | Blogs | Healthcare | Consulting
Contact: info@ipharmacenter.com
GSK's Nucala Receives Approval in Japan for Treating Adults with Chronic Rhinosinusitis with Nasal Polyps | iPharmaCenter
GSK’s Omjjara (Momelotinib) Receives Approval in Japan for Myelofibrosis Treatment | 2024 | iPharmaCenter
Japan Drug Approvals | March 2024 | PMDA | MHLW Updates | iPharmaCenter
Drug approvals in Japan | PMDA | MHLW Approvals | 2022 | News | Media | Japan | iPharmaCenter
Novartis and BeiGene collaboration strengthens the Swiss drugmaker's oncology portfolio
Gilead received the approval of Jyseleca from the European and Japan regulatory authorities for RA
AZ received one more approval in Japan, received approval of Imfinzi for SCLC
JAPAN HEALTHCARE SYSTEM
Eisai's Dayvigo was approved in Japan and Hong Kong for insomnia
AstraZeneca's Lokelma approved in Japan
